Heme-induced corpus cavernosum relaxation and its implications for priapism in sickle cell disease: a mechanistic insight

Autor(es)

Pereira, Dalila Andrade ; Pereira, Danillo Andrade ; Silveira, Tammyris Helena Rebecchi ; Calmasini, Fabiano Beraldi ; Burnett, Arthur L. ; Costa, Fernando Ferreira ; Silva, Fabio Henrique

• Tipo de documento: Artigo Científico
• Fonte: ANDROLOGY; v. 12, n. 8, p. 8-pg., 2024-01-17.

Resumo

BackgroundPatients with sickle cell disease (SCD) experience intravascular hemolysis, leading to elevated plasma heme levels. This phenomenon has been associated with increased priapism in men with SCD. The heme group can be metabolized by heme oxygenase (HO), generating carbon monoxide (CO), which is known to promote smooth muscle relaxation via soluble guanylyl cyclase (sGC)-cyclic guanosine monophosphate (cGMP). However, the effects of heme on the relaxation responses of corpus cavernosum (CC) have not been investigated.ObjectivesTo evaluate the functional and biochemical effects of the heme group on mouse CC smooth muscle in vitro.Materials and methodsMale C57BL/6 mice were used. CC tissues were mounted in organ baths. Measurement of cGMP in mice CC was evaluated.ResultsThe cumulative addition of heme concentrations promoted the relaxation of CC. HO inhibitor (1J, 100 mu M) or sGC inhibitor (ODQ, 10 mu M) blocked the relaxing effect of the heme group. Pre-incubation of CC with heme (100 mu M) enhanced relaxation induced by acetylcholine, sodium nitroprusside, and nitrergic relaxation (electrical field stimulation), which was abolished by 1J or ODQ. The heme group increased the cGMP production in CC, which was abolished by 1J or ODQ. cGMP levels were significantly higher in CC treated with heme, and pre-incubation with compound 1J or ODQ abolished the effect of heme in raising cGMP levels.Discussion and conclusionThe HO-CO-sGC-cGMP pathway appears to play a crucial role in promoting CC relaxation. Our study provides novel insight into the role of group heme in CC relaxation and its potential contribution to priapism in SCD. Heme may serve as a pharmacological target for new therapies to prevent priapism. (AU)

• Processo FAPESP: 19/18886-1 - Mecanismos fisiopatológicos e tratamento das anormalidades das células vermelhas do sangue
• Beneficiário: Fernando Ferreira Costa
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 17/08122-9 - Priapismo e disfunção miccional na Anemia Falciforme: fisiopatologia e novos candidatos a fármacos
• Beneficiário: Fábio Henrique da Silva
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores